{{text}}
| Global rank | 789 299 |
|---|---|
| Daily visitors | 25 |
| Daily pageviews | 25 |
| Pageviews per user | 1 |
| Rating | |
|---|---|
| Latest check |
Pharmatechoutlook.com is tracked by us since November, 2015. Over the time it has been ranked as high as 164 099 in the world, while most of its traffic comes from USA, where it reached as high as 100 167 position. Drug-discovery-and-development.pharmatechoutlook.com receives about 2.31% of its total traffic. It was hosted by Amazon Technologies Inc.. While GODADDY.COM LLC was its first registrar, now it is moved to GoDaddy.com LLC.
Drug-discovery-and-development.pharmatechoutlook has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Drug-discovery-and-development.pharmatechoutlook.com is poorly ‘socialized’ in respect to any social network. According to Siteadvisor and Google safe browsing analytics, Drug-discovery-and-development.pharmatechoutlook.com is quite a safe domain with no visitor reviews.
Pharmatechoutlook.com gets 79.04% of its traffic from USA where it is ranked #125719.
Top Countries
|
|
79.0% |
|
|
2.9% |
|
|
2.5% |
|
|
1.6% |
|
|
1.4% |
Top Ranks
|
|
86 711 |
|
|
125 719 |
|
|
306 131 |
|
|
363 733 |
|
|
365 870 |
Drug-discovery-and-development.pharmatechoutlook.com has 25 visitors and 25 pageviews daily.
Pageviews
Pharmacovigilance.pharmatechoutlook.com is the most popular subdomain of Pharmatechoutlook.com with 5.05% of its total traffic.
Top Subdomains
pharmacovigilance.pharmatechoutlook.com
5.05%
enterprise-software.pharmatechoutlook.com
4.88%
4.33%
biotech-startup.pharmatechoutlook.com
3.86%
other
43.89%
This Subdomain
Drug-discovery-and-development.pharmatechoutlook.com is not yet effective in its SEO tactics: it has Google PR 0. It may also be penalized or lacking valuable inbound links.
Ranks
0
Google PR
-
Yandex CY
| Homepage Top Backlinks | PR |
|---|---|
| No data |
Metadata Updates
Get more Drug-discovery-and-development.pharmatechoutlook.com metadata updates
{{text}}
| Top Keywords | % of search traffic |
|---|---|
| No data |
Drug-discovery-and-development.pharmatechoutlook.com domain is owned by Registration Private Domains By Proxy, LLC and its registration expires in 1 month.
General
Get more Drug-discovery-and-development.pharmatechoutlook.com whois history
Registration Private Domains By Proxy, LLC
Owner since April 13, 2022
1 month left
Expires on January 08, 2025
10 years old
Created on January 08, 2014
10 months ago
Changed at January 09, 2024
In Other TLDs
No data
It seems Drug-discovery-and-development.pharmatechoutlook.com has no mentions in social networks.
Drug-discovery-and-development.pharmatechoutlook.com is hosted by Amazon Technologies Inc.
IP Whois
Get more Drug-discovery-and-development.pharmatechoutlook.com server history
Amazon Technologies Inc.
52.33.124.163
IP address
Server technologies
Apache HTTP Server
Backend server
DNS Records
Host
drug-discovery-and-development.pharmatechoutlook.com
Value
52.33.124.163
ttl
300
Nameservers
No data
Safety status of Drug-discovery-and-development.pharmatechoutlook.com is described as follows: Google Safe Browsing reports its status as safe.
MyWOT
| Overall reputation | Unknown |
|---|---|
| Trustworthiness | Unknown |
| Privacy | Unknown |
| Child safety | Unknown |
Google Safe Browsing
| Website status | Safe |
|---|---|
| Status | ok |
User reviews
| Reputation | Unknown |
|---|
0
Positive0
NegativeRecently analyzed sites